AAAAAA

   
Results: 1-10 |
Results: 10

Authors: SIMMONS M PORTER KR ESCAMILLA J GRAHAM R WATTS DM ECKELS KH HAYES CG
Citation: M. Simmons et al., EVALUATION OF RECOMBINANT DENGUE VIRAL ENVELOPE-B DOMAIN PROTEIN ANTIGENS FOR THE DETECTION OF DENGUE COMPLEX-SPECIFIC ANTIBODIES, The American journal of tropical medicine and hygiene, 58(2), 1998, pp. 144-151

Authors: SITZ KV LOOMISPRICE LD KIM SR KENNER JR SAU P ECKELS KH REDFIELD RR BIRX DL
Citation: Kv. Sitz et al., DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING V3 LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HIV-INFECTED INDIVIDUALS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 208-208

Authors: SITZ KV LOOMISPRICE LD RATTOKIM S KENNER JR SAU P ECKELS KH REDFIELD RR BIRX DL
Citation: Kv. Sitz et al., DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING 3RD VARIABLE LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS, The Journal of infectious diseases, 176(4), 1997, pp. 1085-1089

Authors: PURI B NELSON WM HENCHAL EA HOKE CH ECKELS KH DUBOIS DR PORTER KR HAYES CG
Citation: B. Puri et al., MOLECULAR ANALYSIS OF DENGUE VIRUS ATTENUATION AFTER SERIAL PASSAGE IN PRIMARY DOG KIDNEY-CELLS, Journal of General Virology, 78, 1997, pp. 2287-2291

Authors: PUTNAK R BARVIR DA BURROUS JM DUBOIS DR DANDREA VM HOKE CH SADOFF JC ECKELS KH
Citation: R. Putnak et al., DEVELOPMENT OF A PURIFIED, INACTIVATED, DENGUE-2 VIRUS-VACCINE PROTOTYPE IN VERO CELLS - IMMUNOGENICITY AND PROTECTION IN MICE AND RHESUS-MONKEYS, The Journal of infectious diseases, 174(6), 1996, pp. 1176-1184

Authors: MACKOWIAK PA WASSERMAN SS TACKET CO VAUGHN DW ECKELS KH DUBOIS DR HOKE CH EDELMAN R
Citation: Pa. Mackowiak et al., QUANTITATIVE RELATIONSHIP BETWEEN ORAL-TEMPERATURE AND SEVERITY OF ILLNESS FOLLOWING INOCULATION WITH CANDIDATE ATTENUATED DENGUE VIRUS-VACCINES, Clinical infectious diseases, 19(5), 1994, pp. 948-950

Authors: EDELMAN R TACKET CO WASSERMAN SS VAUGHN DW ECKELS KH DUBOIS DR SUMMERS PL HOKE CH
Citation: R. Edelman et al., A LIVE ATTENUATED DENGUE-1 VACCINE CANDIDATE (45AZ5) PASSAGED IN PRIMARY DOG KIDNEY-CELL CULTURE IS ATTENUATED AND IMMUNOGENIC FOR HUMANS, The Journal of infectious diseases, 170(6), 1994, pp. 1448-1455

Authors: ECKELS KH DUBOIS DR SUMMERS PL SCHLESINGER JJ SHELLY M COHEN S ZHANG YM LAI CJ KURANE I ROTHMAN A HASTY S HOWARD B
Citation: Kh. Eckels et al., IMMUNIZATION OF MONKEYS WITH BACULOVIRUS-DENGUE TYPE-4 RECOMBINANTS CONTAINING ENVELOPE AND NONSTRUCTURAL PROTEINS - EVIDENCE OF PRIMING AND PARTIAL PROTECTION, The American journal of tropical medicine and hygiene, 50(4), 1994, pp. 472-478

Authors: SUMMERS PL DUBOIS DR COHEN WH MACARTHY PO BINN LN SJOGREN MH SNITBHAN R INNIS BL ECKELS KH
Citation: Pl. Summers et al., SOLID-PHASE ANTIBODY CAPTURE HEMADSORPTION ASSAY FOR DETECTION OF HEPATITIS-A VIRUS IMMUNOGLOBULIN-M ANTIBODIES, Journal of clinical microbiology, 31(5), 1993, pp. 1299-1302

Authors: GREEN S KURANE I EDELMAN R TACKET CO ECKELS KH VAUGHN DW HOKE CH ENNIS FA
Citation: S. Green et al., DENGUE VIRUS-SPECIFIC HUMAN CD4-LYMPHOCYTE RESPONSES IN A RECIPIENT OF AN EXPERIMENTAL LIVE-ATTENUATED DENGUE VIRUS TYPE-1 VACCINE - BULK CULTURE PROLIFERATION, CLONAL ANALYSIS, AND PRECURSOR FREQUENCY DETERMINATION( T), Journal of virology, 67(10), 1993, pp. 5962-5967
Risultati: 1-10 |